Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 71335-2121

8 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 71335-2121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Fig 1)

Figure 1 (Fig 1)
A line graph showing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours comparing oxybutynin chloride extended-release tablets 10 mg once daily (QD) and oxybutynin 5 mg three times daily (TID). Concentration values fluctuate over time with error bars indicating variability at each time point.*
FDA Label Image

Figure 2 (Fig 2)

Figure 2 (Fig 2)
A line graph depicting mean R-Oxybutynin plasma concentration (ng/mL) over time (hours) up to 24 hours. The y-axis ranges from 0 to 2.0 ng/mL, and the x-axis ranges from 0 to 24 hours. Mean concentration peaks around 4 to 6 hours and shows error bars at each time point, illustrating variability in plasma levels.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A horizontal bar chart comparing Oxybutynin chloride extended-release tablets to placebo. The chart displays data points and confidence intervals for each, with values ranging approximately from -40 to +40 on the axis, illustrating a statistical comparison between the two treatments.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A horizontal error bar chart comparing two data points labeled 'Oxybutynin chloride extended-release tablets' and 'oxybutynin'. The x-axis ranges from -40 to 40; the data points have horizontal error bars extending on either side. No additional context or values are visible.*
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
A horizontal error bar chart depicting data for oxybutynin chloride extended-release tablets and oxybutynin. The chart shows mean values with error ranges on a scale from -40 to 40, with the extended-release tablets indicated above oxybutynin.*
FDA Label Image

Label (Lbl713352121)

Label (Lbl713352121)
Oxybutynin Chloride Extended Release 10 mg tablet label shows the drug name, strength, and dosage form. It is packaged by Bryant Ranch Prepack in Burbank, CA, with an NDC of 71335-2121. The label compares to Ditropan XL 10 mg tablet from Unique Pharmaceutical Laboratories. Storage instructions and a barcode are also visible.*
FDA Label Image
Rising Logo (Rising Logo)
FDA Label Image

Structure (Structural Formula)

Structure (Structural Formula)
Chemical structure diagram of oxybutynin chloride, showing its molecular components and arrangement including a phenyl group, ester linkage, alkyne, and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.